PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY APPLICATION Market segmentation by application Comparison by application Wound healing - Market size and forecast 2018-2023 Drug delivery - Market size and forecast 2018-2023 Tissue engineering - Market size and forecast 2018-2023 Others - Market size and forecast 2018-2023 Market opportunity by application PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES Market drivers Market challenges PART 11: MARKET TRENDS Technical innovations Strategic alliances Increasing number of applications in cosmetic industry PART 12: VENDOR LANDSCAPE Overview Landscape disruption Competitive scenario PART 13: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Advanced Medical Solutions Group Plc Axelgaard Manufacturing Co. Ltd. Cardinal Health Inc. Hydromer Inc. Scapa Group Plc PART 14: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Key offerings Exhibit 02: Global biotechnology market Exhibit 03: Segments of global biotechnology market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Population aged 65 and above (% of total population) 2010-2018 Exhibit 10: Global market: Year-over-year growth 2019-2023 (%) Exhibit 11: Five forces analysis 2018 Exhibit 12: Five forces analysis 2023 Exhibit 13: Bargaining power of buyers Exhibit 14: Bargaining power of suppliers Exhibit 15: Threat of new entrants Exhibit 16: Threat of substitutes Exhibit 17: Threat of rivalry Exhibit 18: Market condition - Five forces 2018 Exhibit 19: Application - Market share 2018-2023 (%) Exhibit 20: Comparison by application Exhibit 21: Wound healing - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Wound healing - Year-over-year growth 2019-2023 (%) Exhibit 23: Drug delivery - Market size and forecast 2018-2023 ($ millions) Exhibit 24: Drug delivery - Year-over-year growth 2019-2023 (%) Exhibit 25: Tissue engineering - Market size and forecast 2018-2023 ($ millions) Exhibit 26: Tissue engineering - Year-over-year growth 2019-2023 (%) Exhibit 27: Others - Market size and forecast 2018-2023 ($ millions) Exhibit 28: Others - Year-over-year growth 2019-2023 (%) Exhibit 29: Market opportunity by application Exhibit 30: Customer landscape Exhibit 31: Market share by geography 2018-2023 (%) Exhibit 32: Geographic comparison Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 34: North America - Year-over-year growth 2019-2023 (%) Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 36: Europe - Year-over-year growth 2019-2023 (%) Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 38: Asia - Year-over-year growth 2019-2023 (%) Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 40: ROW - Year-over-year growth 2019-2023 (%) Exhibit 41: Key leading countries Exhibit 42: Market opportunity Exhibit 43: Impact of drivers and challenges Exhibit 44: Vendor landscape Exhibit 45: Landscape disruption Exhibit 46: Vendors covered Exhibit 47: Vendor classification Exhibit 48: Market positioning of vendors Exhibit 49: Advanced Medical Solutions Group Plc - Vendor overview Exhibit 50: Advanced Medical Solutions Group Plc - Business segments Exhibit 51: Advanced Medical Solutions Group Plc - Organizational developments Exhibit 52: Advanced Medical Solutions Group Plc - Geographic focus Exhibit 53: Advanced Medical Solutions Group Plc - Segment focus Exhibit 54: Advanced Medical Solutions Group Plc - Key offerings Exhibit 55: Axelgaard Manufacturing Co. Ltd. - Vendor overview Exhibit 56: Axelgaard Manufacturing Co. Ltd. - Product segments Exhibit 57: Axelgaard Manufacturing Co. Ltd. - Key offerings Exhibit 58: Cardinal Health Inc. - Vendor overview Exhibit 59: Cardinal Health Inc. - Business segments Exhibit 60: Cardinal Health Inc. - Organizational developments Exhibit 61: Cardinal Health Inc. - Geographic focus Exhibit 62: Cardinal Health Inc. - Segment focus Exhibit 63: Cardinal Health Inc. - Key offerings Exhibit 64: Hydromer Inc. - Vendor overview Exhibit 65: Hydromer Inc. - Product segments Exhibit 66: Hydromer Inc. - Organizational developments Exhibit 67: Hydromer Inc. - Geographic focus Exhibit 68: Hydromer Inc. - Segment focus Exhibit 69: Hydromer Inc. - Key offerings Exhibit 70: Scapa Group Plc - Vendor overview Exhibit 71: Scapa Group Plc - Business segments Exhibit 72: Scapa Group Plc - Organizational developments Exhibit 73: Scapa Group Plc - Geographic focus Exhibit 74: Scapa Group Plc - Segment focus Exhibit 75: Scapa Group Plc - Key offerings Exhibit 76: Validation techniques employed for market sizing Exhibit 77: Definition of market positioning of vendors

Advanced Medical Solutions Group Plc, Axelgaard Manufacturing Co. Ltd., Cardinal Health Inc., Hydromer Inc., and Scapa Group Plc.